Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Legend Biotech Corporation Sponsored ADR (LEGN) vs Relay Therapeutics, Inc. (RLAY)

Legend Biotech Corporation Sponsored ADR and Relay Therapeutics, Inc. are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR and Relay Therapeutics, Inc. are of similar size ($3.9B and $3.7B). Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against −74.3%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −2,594.2%) and the lower return on invested capital (−9.54% vs 0.00%). Across the 18 metrics below, Legend Biotech Corporation Sponsored ADR leads on 12 and Relay Therapeutics, Inc. on 6.

Valuation

Metric LEGN RLAY Biotechnology median
P/E n/m n/m 7.88
P/S 2.81 323.06 11.47
P/B 2.91 4.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.31 240.44 10.73
Earnings yield (2.59%) (8.94%) (28.84%)
Free cash flow yield (3.42%) (5.97%) (23.03%)

Profitability

Metric LEGN RLAY Biotechnology median
Gross margin 56.58% 100.00% 65.16%
Operating margin (5.06%) (2,815.49%) 0.00%
Net margin (7.20%) (2,594.20%) 0.00%
Free cash flow margin (9.58%) (1,924.59%) 0.00%
Return on equity (8.08%) (36.77%) (57.72%)
Return on assets (5.32%) (33.72%) (49.22%)
Return on invested capital (9.54%) 0.00% 0.00%

Growth

Metric LEGN RLAY Biotechnology median
Revenue growth (TTM) 59.55% (74.29%) 5.64%
EPS growth (last fiscal year) (66.34%) 31.78% —
Revenue growth, 5-year CAGR 65.93% (28.58%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEGN RLAY Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 3.04 18.27 4.73
Net debt to EBITDA 2.31 1.84 0.96

Dividend

Metric LEGN RLAY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LEGN RLAY Biotechnology median
Market cap 3.69b 3.91b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack